Effects of hypoxia on granulocytic-monocytic progenitors in rats. Role of bone marrow stroma

American Journal of Hematology

Volumn 64, Issue 1, 2000, Pages 20-25

  Taneja, Rashmi ^a   Rameshwar, Pranela ^a   Upperman, Jeffrey ^a   Wang, Ming T ^a   Livingston, David H ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

Bone marrow; Hematopoiesis; Hemorrhagic shock; Hypoxia; Transforming growth factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DEPRESSION; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMATOPOIESIS; HEMORRHAGIC SHOCK; HYPOXIA; IMMUNOREGULATION; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034051827     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-8652(200005)64:1<20::aid-ajh4>3.0.co;2-%23     Document Type: Article

References (40)

1. Nichols RL, Smith JW, Klein DB, Trunkey DD, Cooper RH, Adinolfi MF, Mills J. Risk of infection in abdominal trauma. N Engl J Med 1984;311:1065-1070.
2. Stephan RN, Kupper TS, Geha AS, Baue AE, Chaudry IH. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987;122:62-68.
3. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995:75:257-277.
4. Dever LL, Johanson WG: Pneumonia complicating adult respiratory distress syndrome. Clinics Chest Med 1995;16:147-153.
5. Livingston DH, Gentile PS, Malangoni MA. Bone marrow failure after hemorrhagic shock. Circ Shock 1990;30:255-263.
6. Livingston DH, Wang TW, Hsieh J, Murphy TF, Rush BF Jr. Hemorrhagic shock inhibits lipopolysaccharide-induced myelopoiesis in both germ-free and conventional rats. Surgery 1992;112:773-779.
7. Xu YX, Ayala A, Chaudry IH. Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma 1998:44:335-341.
8. Xu YX, Wichmann MW, Ayala A, Cioffi WG, Chaudry IH. Traumahemorrhage induces increased thymic apoptosis while decreasing IL-3 release and increasing GM-CSF, J Surg Res 1997:68:24-30.
9. Zellweger R, Ayala A, DeMaso CM, Chaudry IH. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 1995;4:149-153.
10. Zellweger R, Ayala A, Schmand JF, Morrison MH, Chaudry IH. PAF-antagonist administration after hemorrhage-resuscitation prevents splenocyte immunodepression. J Surg Res 1995:59:366-370.
11. Schmand JF, Ayala A, Morrison MH, Chaudry IH. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med 1995;23:806-814.
12. Zellweger R, Wichmann MW, Ayala A. Chaudry IH. Metoclopramide: a novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage. J Trauma 1998:44: 70-77.
13. Livingston DH. Interferon-gamma reverses bone marrow inhibition following hemorrhagic shock. Arch Surg 1991;126:100-103.
14. Mohr AM, Upperman JS, Taneja R, Wang MT, Rameshwar P, Livingston DH. Differential effects of acute hypoxia and endotoxin on the secretion and expression of bone marrow interleukin-1 and interleukin-6. Shock 1997;7:324-331.
15. Angele MK, Schwacha MG, Smail N, Catania RA, Ayala A, Cioffi WG, Chaudry IH. Hypoxemia in the absence of blood loss upregulates iNOS expression and activity in macrophages. Am J Physiol 1999; 279:C285-C290.
16. Wang P, Ba ZF, Chaudry IH. Severe hypoxemia in the absence of blood loss depresses hepatocellular function and up-regulates IL-6 and PGE2. Biochim Biophys Acta 1997;1361:42-48.
17. Quinlan DP Jr, Rameshwar P, Qian J, Maloof PB, Mohr AM. Hauser CJ, Livingston DH. Effect of hypoxia on the hematopoietic/immune modulator preprotachykinin-I. Arch Surg 1998;133:1328-1334.
18. Quinlan DP Jr, Rameshwar P, Hauser C, Livingston D. The effect of hypoxia on bone marrow myeloid and erythroid progenitor cells. Surg Forum 1998;49:35-37.
19. Xu DZ, Lu Q, Kubicka R, Deitch EA. The effect of hypoxia/ reoxygenation on the cellular function of intestinal epithelial cells. J Trauma 1999;46:280-285.
20. Rollwagen FM. Yu ZY, Li YY, Pacheco ND. IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin Immunol Immunopathol 1998;89:205-213.
21. Knowles R, Keeping H, Graeber T, Nguyen K, Garner C D' Amico R, Simms HH. Cytokine control of PMN phagocytosis: regulatory effects of hypoxemia and hypoxemia-reoxygenation. Am J Physiol 1997;272: C1352-C1364.
22. Ertel W, Morrison MH, Ayala A, Chaudry IH. Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. Am J Physiol 1995;269:R160-R166.
23. Rameshwar P, Denny T, Stein D. Gascón P. Adhesion of monocytes from patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for IL-1 and TGF-β. J Immunol 1994;153:2819-2830.
24. Chaudry IH, Sayeed MM, Baue AE. Difference in the altered energy metabolism of hemorrhagic shock and hypoxemia. Can J Physiol Pharmacol 1976;54:750-756.
25. Metcalf D, Johnson GR, Mandel TE. Colony formation in agar by multi-potential hematopoietic cells. J Cell Physiol 1979;98:401-420.
26. Rameshwar P, Denny TN, Gascón P. Enhanced HIV-1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24. J Immunol 1996;157:4244-4250.
27. Rameshwar P, Gascón P. Release of interleukin-1 and interleukin-6 from human monocytes by antithymocyte globulin: requirement for de novo synthesis. Blood 1992;80:2531-2538.
28. Coombe DR. The role of stromal cell heparan sulphate in regulating haemopoiesis. Leuk Lymph 1995;21:399-406.
29. Niemeyer CM, Sieff CA, Mathet-Prevot B, Wimperis JZ, Bierer BE, Clark SC, Nathan DG. Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T cell tumor lines. Blood 1989;73:945-951.
30. Nemunaitis J. Biological activities of hematopoietic growth factors that lead to future clinical application. Can Invest 1994;12:516-529.
31. Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang Y-C, Clark SC, Ogawa M. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: Comparison with interleukin-1α. Blood 1988;71:1759-1763.
32. Keller JR, Jacobsen EW, Dubois CM, Hestdal K, Ruscetti FW. Transforming growth factor-β: a bidirectional regulator of hematopoietic cell growth, Int J Cell Cloning 1992;10:2-11.
33. Rameshwar P, Gascón P. Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 1996;88:98-106.
34. Rameshwar P, Gascón P. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk Lymph 1998; 28:1-10.
35. Rameshwar P. Substance P: a regulatory neuropeptide for hematopoiesis and immune functions. Molecule of the Month Section. Clin Immunol Immunopathol 1997;85:120-133.
36. Nakai S, Hirai Y. The therapeutic potential of interleukin-Iβ in the treatment of chemotherapy-or radiation-induced myelosuppression and in tumor therapy. Biotherapy 1989;1:339-354.
37. Neta R. Douches S, Oppenheim JJ. Interleukin 1 is a radioprotector. J Immunol 1986;136:2483-2485.
38. Metcalf D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspect. Science 1991;254:529-533.
39. Ayala A, Ertel W, Chaudry IH. Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 1996;5:79-90.
40. Wichmann MW, Zellweger R, DeMaso CM, Ayala A. Williams C, Chaudry IH. Immune function is more compromised after closed bone fracture and hemorrhagic shock than hemorrhage alone. Arch Surg 1996;131:995-1000.